🟢 Surgepays is trading 12.2% up in pre-market — no confirmed company-specific catalyst

Surgepays is trading at $0.16, up 12.15% in pre-market, with no verified company-specific announcement identified for October 28, 2026.

• The GrowthLine launch was announced October 15, not overnight.
• Reports cite renewed AI optimism and gains in tech shares ahead of major earnings and the Federal Reserve decision. Supportive technology sentiment is context, not a confirmed cause.
• Surgepays had also risen 7.56% in recent sessions, including October 27, according to the supplied price context; available evidence does not establish a direct catalyst.